Syros Pharmaceuticals, Inc. (SYRS)

OTCMKTS · Delayed Price · Currency is USD

0.0002

-0.0006 (-75.00%)

At close: Mar 5, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Biotechnology	9.94M	14.88M	23.49M	15.09M	1.98M
Biotechnology Growth	-33.23%	-36.65%	55.62%	661.50%	-3.32%
Total	9.94M	14.88M	23.49M	15.09M	1.98M
Total Growth	-33.23%	-36.65%	55.62%	661.50%	-3.32%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
United States	9.94M	14.88M	23.49M	15.09M	1.98M
United States Growth	-33.23%	-36.65%	55.62%	661.50%	-3.32%
Total	9.94M	14.88M	23.49M	15.09M	1.98M
Total Growth	-33.23%	-36.65%	55.62%	661.50%	-3.32%

Source: S&P Global Market Intelligence.